JP2018184448A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018184448A5 JP2018184448A5 JP2018139536A JP2018139536A JP2018184448A5 JP 2018184448 A5 JP2018184448 A5 JP 2018184448A5 JP 2018139536 A JP2018139536 A JP 2018139536A JP 2018139536 A JP2018139536 A JP 2018139536A JP 2018184448 A5 JP2018184448 A5 JP 2018184448A5
- Authority
- JP
- Japan
- Prior art keywords
- hematopoietic stem
- cells
- cell
- use according
- progenitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37321210P | 2010-08-12 | 2010-08-12 | |
| US61/373,212 | 2010-08-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018031941A Division JP6574279B2 (ja) | 2010-08-12 | 2018-02-26 | 改善された造血幹細胞および前駆細胞療法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019197587A Division JP2020029458A (ja) | 2010-08-12 | 2019-10-30 | 改善された造血幹細胞および前駆細胞療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018184448A JP2018184448A (ja) | 2018-11-22 |
| JP2018184448A5 true JP2018184448A5 (enExample) | 2019-01-10 |
Family
ID=45568224
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524254A Expired - Fee Related JP6047489B2 (ja) | 2010-08-12 | 2011-08-12 | 改善された造血幹細胞および前駆細胞療法 |
| JP2016124416A Expired - Fee Related JP6346917B2 (ja) | 2010-08-12 | 2016-06-23 | 改善された造血幹細胞および前駆細胞療法 |
| JP2018031941A Expired - Fee Related JP6574279B2 (ja) | 2010-08-12 | 2018-02-26 | 改善された造血幹細胞および前駆細胞療法 |
| JP2018139536A Withdrawn JP2018184448A (ja) | 2010-08-12 | 2018-07-25 | 改善された造血幹細胞および前駆細胞療法 |
| JP2019197587A Withdrawn JP2020029458A (ja) | 2010-08-12 | 2019-10-30 | 改善された造血幹細胞および前駆細胞療法 |
| JP2021172986A Withdrawn JP2022009404A (ja) | 2010-08-12 | 2021-10-22 | 改善された造血幹細胞および前駆細胞療法 |
| JP2023071598A Pending JP2023109761A (ja) | 2010-08-12 | 2023-04-25 | 改善された造血幹細胞および前駆細胞療法 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524254A Expired - Fee Related JP6047489B2 (ja) | 2010-08-12 | 2011-08-12 | 改善された造血幹細胞および前駆細胞療法 |
| JP2016124416A Expired - Fee Related JP6346917B2 (ja) | 2010-08-12 | 2016-06-23 | 改善された造血幹細胞および前駆細胞療法 |
| JP2018031941A Expired - Fee Related JP6574279B2 (ja) | 2010-08-12 | 2018-02-26 | 改善された造血幹細胞および前駆細胞療法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019197587A Withdrawn JP2020029458A (ja) | 2010-08-12 | 2019-10-30 | 改善された造血幹細胞および前駆細胞療法 |
| JP2021172986A Withdrawn JP2022009404A (ja) | 2010-08-12 | 2021-10-22 | 改善された造血幹細胞および前駆細胞療法 |
| JP2023071598A Pending JP2023109761A (ja) | 2010-08-12 | 2023-04-25 | 改善された造血幹細胞および前駆細胞療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20140030232A1 (enExample) |
| EP (2) | EP2603227B1 (enExample) |
| JP (7) | JP6047489B2 (enExample) |
| CN (5) | CN106214701B (enExample) |
| AU (1) | AU2011289245B2 (enExample) |
| BR (1) | BR112013003366A2 (enExample) |
| CA (1) | CA2807944C (enExample) |
| ES (1) | ES2654994T3 (enExample) |
| WO (1) | WO2012021845A2 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106214701B (zh) * | 2010-08-12 | 2020-09-25 | 菲特治疗公司 | 改进的造血干细胞和祖细胞疗法 |
| JP6106688B2 (ja) | 2011-12-02 | 2017-04-05 | フェイト セラピューティクス，インコーポレイテッド | 虚血を処置する改善された方法 |
| WO2013082243A1 (en) * | 2011-12-02 | 2013-06-06 | Fate Therapeutics, Inc. | Enhanced stem cell composition |
| US20150329643A1 (en) * | 2012-11-16 | 2015-11-19 | Albert Einstein College Of Medicine Of Yeshiva University | Identification and use of new tumor-promoting gene in hematological malignancies |
| SG11201506520TA (en) * | 2013-02-18 | 2015-09-29 | Univ Health Network | Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells |
| AU2014236285A1 (en) * | 2013-03-14 | 2015-11-05 | Children's Medical Center Corporation | Compositions and methods for reprogramming hematopoietic stem cell lineages |
| US10851412B2 (en) | 2013-03-15 | 2020-12-01 | Fate Therapeutics, Inc. | Cell potency assay for therapeutic potential |
| US9943545B2 (en) | 2013-03-15 | 2018-04-17 | Fate Therapeutics, Inc. | Stem cell culture media and methods of enhancing cell survival |
| CN105408472A (zh) | 2013-03-15 | 2016-03-16 | 马卡斯凯尔·托莱夫·拉尔森 | 用于脐带血收集及细胞分离的细胞、方法和装置 |
| RU2525143C1 (ru) * | 2013-03-22 | 2014-08-10 | Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации-Институт медико-биологических проблем Российской академии наук | СПОСОБ ЭКСПАНСИИ МОНОНУКЛЕАРНЫХ КЛЕТОК ПУПОВИННОЙ КРОВИ (пкМНК) ex vivo В ПРИСУТСТВИИ МУЛЬТИПОТЕНТНЫХ СТРОМАЛЬНЫХ МЕЗЕНХИМАЛЬНЫХ КЛЕТОК (ММСК) |
| WO2015077691A2 (en) * | 2013-11-22 | 2015-05-28 | Washington University | Biomarkers for multiple myeloma |
| WO2016011381A1 (en) | 2014-07-18 | 2016-01-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Reducing cxcr4 expression and/or function to enhance engraftment of hematopoietic stem cells |
| JP2018504122A (ja) * | 2015-01-26 | 2018-02-15 | フェイト セラピューティクス，インコーポレイテッド | 免疫調節特性が増加した細胞ならびにその使用および製造のための方法 |
| US10626372B1 (en) | 2015-01-26 | 2020-04-21 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| WO2016164502A1 (en) * | 2015-04-06 | 2016-10-13 | President And Fellows Of Harvard College | Compositions and methods for non-myeloablative conditioning |
| CA2993014A1 (en) * | 2015-07-20 | 2017-01-26 | Angiocrine Bioscience, Inc. | Methods and compositions for stem cell transplantation |
| BR112018001232A2 (pt) | 2015-07-21 | 2018-09-25 | The Children's Medical Center Corporation | pd-l1 que expressa células-tronco hematopoéticas e usos |
| CN108473961B (zh) | 2015-11-04 | 2022-11-29 | 菲特治疗公司 | 用于诱导造血细胞分化的方法和组合物 |
| KR20250141836A (ko) | 2015-11-04 | 2025-09-29 | 페이트 세러퓨틱스, 인코포레이티드 | 만능 세포의 유전자 조작 |
| RU2628092C1 (ru) * | 2016-02-10 | 2017-08-14 | Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации - Институт медико-биологических проблем Российской академии наук (ГНЦ РФ - ИМБП РАН) | Способ получения МСК-ассоциированных недифференцированных гемопоэтических клеток-предшественников с фенотипов CD34+/CD133+ |
| CN105779386B (zh) * | 2016-04-06 | 2019-09-20 | 南京大学 | 一种间充质干细胞在制备治疗m5型白血病药物中的应用 |
| CN105886457A (zh) * | 2016-05-16 | 2016-08-24 | 中国人民解放军军事医学科学院野战输血研究所 | 诱导干细胞分化成外胚层祖细胞的方法 |
| US11542473B2 (en) | 2016-10-21 | 2023-01-03 | Amniotics Ab | Methods and compositions for generating hematopoietic cells |
| CN106754726A (zh) * | 2016-12-28 | 2017-05-31 | 溯源生命科技股份有限公司 | 一种提高人间充质干细胞移植和归巢效率的基因治疗方法 |
| US20200051666A1 (en) * | 2017-03-14 | 2020-02-13 | Orig3N, Inc. | HLA-INDEXED REPOSITORY OF iPSCS AND iPSC-DERIVED STEM CELLS, AND RELATED SYSTEMS AND METHODS |
| WO2019060708A1 (en) | 2017-09-22 | 2019-03-28 | The Children's Medical Center Corporation | TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS |
| EP3647413A1 (en) * | 2018-10-31 | 2020-05-06 | Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas O.A., M.P. (CIEMAT) | Improvements for performing and facilitating the recovery after hematopoietic stem cell transplantation |
| MX2021014039A (es) * | 2019-05-17 | 2022-02-11 | Deverra Therapeutics Inc | Composiciones y métodos para mejorar resultados de tratamiento para pacientes que tienen neoplasias malignas hematológicas usando un producto de células madre expandidas. |
| US20220305057A1 (en) * | 2019-06-06 | 2022-09-29 | Medeor Therapeutics, Inc. | Methods of making cellular products by post- mortem mobilization and harvesting of hematopoietic cells |
| EP3986358A4 (en) | 2019-06-20 | 2023-06-21 | Amniotics AB | DEVICE FOR FILTERING FRUIT WATER |
| CN110585432B (zh) * | 2019-08-27 | 2021-10-15 | 中国人民解放军第二军医大学 | 成纤维细胞生长因子受体1在制备防治肠道病毒71型感染药物中的应用 |
| US20220372444A1 (en) | 2019-10-18 | 2022-11-24 | Amniotics Ab | Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof |
| MX2022005892A (es) * | 2019-11-14 | 2022-06-14 | Amgen Inc | Produccion de celulas precursoras hematopoyeticas. |
| TW202325303A (zh) * | 2020-09-24 | 2023-07-01 | 大陸商廣州輯因醫療科技有限公司 | 化合物用於提高人造血幹細胞移植效率的用途 |
| WO2022089606A1 (en) * | 2020-10-30 | 2022-05-05 | Westlake Therapeutics (Hangzhou) Co. Limited | Methods for preparing mature red blood cells in vitro |
| US12435308B2 (en) | 2020-11-06 | 2025-10-07 | Amniotics Ab | Immunomodulation by amniotic fluid mesenchymal stem cells |
| WO2024040061A2 (en) * | 2022-08-16 | 2024-02-22 | The Regents Of The University Of California | Alleviating graft versus host disease using engineered inkt cells |
| WO2024186146A1 (ko) * | 2023-03-07 | 2024-09-12 | 인제대학교 산학협력단 | 조혈 줄기세포 증식 또는 가동화 촉진용 조성물 및 가동화 조혈 줄기세포 수집방법 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
| US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
| US5409813A (en) | 1993-09-30 | 1995-04-25 | Systemix, Inc. | Method for mammalian cell separation from a mixture of cell populations |
| US5677136A (en) | 1994-11-14 | 1997-10-14 | Systemix, Inc. | Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| US5709472A (en) * | 1995-10-23 | 1998-01-20 | Lifelines Technology, Inc. | Time-temperature indicator device and method of manufacture |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| US5945337A (en) | 1996-10-18 | 1999-08-31 | Quality Biological, Inc. | Method for culturing CD34+ cells in a serum-free medium |
| DE69829402T2 (de) | 1997-10-31 | 2006-04-13 | Affymetrix, Inc. (a Delaware Corp.), Santa Clara | Expressionsprofile in adulten und fötalen organen |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| WO2000038663A2 (en) | 1998-12-24 | 2000-07-06 | Alcon Laboratories, Inc. | Ep4 receptor agonists for treatment of dry eye |
| HK1048302A1 (zh) | 1999-08-13 | 2003-03-28 | 大正制药株式会社 | 前列腺素衍生物 |
| IL141120A0 (en) | 2000-01-31 | 2002-02-10 | Pfizer Prod Inc | Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| CA2483518A1 (en) * | 2002-04-26 | 2003-11-06 | Kirin Beer Kabushiki Kaisha | Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same |
| US6747037B1 (en) | 2003-06-06 | 2004-06-08 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US20050176140A1 (en) * | 2004-02-10 | 2005-08-11 | Benedict Daniel J. | Method and apparatus for cell culture using a two liquid phase bioreactor |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| AU2005299473B2 (en) | 2004-10-26 | 2012-06-28 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin EP4 agonists |
| DE102005062741A1 (de) | 2005-12-22 | 2007-06-28 | Bayer Schering Pharma Ag | Fluorene und Carbazole als Liganden des EP2 Rezeptors |
| CN101495623B (zh) * | 2006-03-24 | 2013-09-11 | 儿童医疗中心有限公司 | 调节造血干细胞生长的方法 |
| CN101517070A (zh) * | 2006-05-31 | 2009-08-26 | Styx有限责任公司 | 选择干细胞的方法及其用途 |
| CN101506353A (zh) * | 2006-06-15 | 2009-08-12 | 尼奥斯泰姆公司 | 外周造血干细胞的处理方法 |
| US20110165128A1 (en) * | 2008-03-07 | 2011-07-07 | Columbia University In The City Of New York | Homing in mesenchymal stem cells |
| EP3031907B1 (en) * | 2008-11-06 | 2021-01-06 | Indiana University Research and Technology Corporation | Materials and methods to enhance hematopoietic stem cells engraftment procedures |
| WO2010065601A1 (en) * | 2008-12-03 | 2010-06-10 | Amorcyte, Inc. | Infarct area perfusion-improving compositions and methods of vascular injury repair |
| JP2010193879A (ja) * | 2009-01-27 | 2010-09-09 | Jms Co Ltd | 臍帯血造血幹細胞の増殖制御方法およびその用途 |
| CN106214701B (zh) * | 2010-08-12 | 2020-09-25 | 菲特治疗公司 | 改进的造血干细胞和祖细胞疗法 |
-
2011
- 2011-08-12 CN CN201610638252.6A patent/CN106214701B/zh not_active Expired - Fee Related
- 2011-08-12 EP EP11817137.0A patent/EP2603227B1/en not_active Not-in-force
- 2011-08-12 JP JP2013524254A patent/JP6047489B2/ja not_active Expired - Fee Related
- 2011-08-12 WO PCT/US2011/047657 patent/WO2012021845A2/en not_active Ceased
- 2011-08-12 ES ES11817137.0T patent/ES2654994T3/es active Active
- 2011-08-12 EP EP17188681.5A patent/EP3278808A1/en not_active Withdrawn
- 2011-08-12 CN CN202011443538.1A patent/CN112501118A/zh active Pending
- 2011-08-12 US US13/816,723 patent/US20140030232A1/en not_active Abandoned
- 2011-08-12 CA CA2807944A patent/CA2807944C/en active Active
- 2011-08-12 AU AU2011289245A patent/AU2011289245B2/en not_active Ceased
- 2011-08-12 CN CN201610635871.XA patent/CN106244547B/zh not_active Expired - Fee Related
- 2011-08-12 CN CN201180049420.3A patent/CN103167876B/zh not_active Expired - Fee Related
- 2011-08-12 CN CN202011436734.6A patent/CN112516167A/zh active Pending
- 2011-08-12 BR BR112013003366-5A patent/BR112013003366A2/pt not_active Application Discontinuation
-
2016
- 2016-06-23 JP JP2016124416A patent/JP6346917B2/ja not_active Expired - Fee Related
-
2018
- 2018-02-26 JP JP2018031941A patent/JP6574279B2/ja not_active Expired - Fee Related
- 2018-07-25 JP JP2018139536A patent/JP2018184448A/ja not_active Withdrawn
-
2019
- 2019-10-30 JP JP2019197587A patent/JP2020029458A/ja not_active Withdrawn
-
2020
- 2020-05-11 US US16/872,061 patent/US20200339953A1/en not_active Abandoned
-
2021
- 2021-10-22 JP JP2021172986A patent/JP2022009404A/ja not_active Withdrawn
-
2023
- 2023-04-25 JP JP2023071598A patent/JP2023109761A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018184448A5 (enExample) | ||
| Kelly et al. | Ex vivo expansion of cord blood | |
| ES2627043T3 (es) | Aumento de la eficacia de la terapia celular incluyendo tratamiento con alfa 1-3 fucoslitransferasa | |
| Fajardo-Orduña et al. | Hematopoietic support capacity of mesenchymal stem cells: biology and clinical potential | |
| Haider et al. | Bone marrow stem cell transplantation for cardiac repair | |
| Malgieri et al. | Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art | |
| Zhong et al. | Feasibility investigation of allogeneic endometrial regenerative cells | |
| Tung et al. | Ex vivo expansion of umbilical cord blood for transplantation | |
| ES2638435T3 (es) | Métodos y medios para proliferación de células madre y posterior generación y expansión de células progenitoras, así como también producción de células efectoras como terapéuticos clínicos | |
| JP2013540105A5 (enExample) | ||
| US20240294873A1 (en) | Methods for the long-term expansion of granulocyte-macrophage progenitors and applications thereof | |
| RU2015134394A (ru) | Перепрограммирование эндотелия человека в гемопоэтических предшественников множественных линий дифференцировки с использованием определенных факторов | |
| Lo Iacono et al. | Wharton’s jelly mesenchymal stromal cells as a feeder layer for the ex vivo expansion of hematopoietic stem and progenitor cells: a review | |
| Oh et al. | Stem cell and exosome therapy in pulmonary hypertension | |
| JP2024016037A5 (enExample) | ||
| US8440460B2 (en) | Methods for transdifferentiating cells | |
| Wang et al. | Allogeneic stem cell transplantation combined with transfusion of mesenchymal stem cells in primary myelofibrosis: a multicenter retrospective study | |
| Kim et al. | Cell therapy with bone marrow cells for myocardial regeneration | |
| Quesenberry et al. | The new stem cell biology | |
| Moghadasi et al. | Expansion of cord blood stem cells in fibronectin-coated microfluidic bioreactor | |
| Turksen | Stem cells: Current challenges and new directions | |
| Aanei et al. | Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated | |
| Cetrulo et al. | Perinatal stem cells | |
| Ren et al. | Umbilical cord blood hematopoietic stem cell expansion ex vivo | |
| Sergeevicheva et al. | Autologous mesenchymal stromal cells of hemoblastosis patients efficiently support hematopoietic recovery after stem cell transplantation |